Results 101 to 110 of about 15,263 (254)

Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.

open access: yes
BACKGROUND Chronic rhinosinusitis with nasal polyps (CRSwNP) frequently leads to olfactory dysfunction. This study aimed to assess the impact of dupilumab on CRSwNP patients, focusing on olfactory outcomes and potential correlations with other ...
Steiner, U C   +6 more
core   +1 more source

Differential Effects of Dupilumab in a Patient With Localized Heat Urticaria, Delayed Solar Urticaria, and Symptomatic Dermographism

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Physical urticaria is a subtype of chronic inducible urticaria characterized by wheals and/or angioedema triggered by physical stimuli. We report a refractory case of combined localized heat urticaria, delayed solar urticaria, and symptomatic dermographism in a 16‐year‐old girl.
Shuta Yoshitani   +2 more
wiley   +1 more source

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT We present three patients who developed allergic contact dermatitis (ACD) from benzalkonium chloride (BAK) in ophthalmic drops. BAK is a preservative commonly found in ophthalmic formulations and there is a rising trend of ACD to this allergen. The irritant and sensitising properties of BAK on the ocular mucosa will be discussed.
Arav Kannen   +2 more
wiley   +1 more source

Comparative Analysis of the Efficacy of Abrocitinib and Dupilumab in the Treatment of Atopic Dermatitis [PDF]

open access: yes
Dan Song, Wei-Ping Gong, Gui-Lin Xiao Department of Dermatology, Zhoushan Hospital, Zhoushan City, Zhejiang Province, 316000, People’s Republic of ChinaCorrespondence: Dan Song, Department of Dermatology, Zhoushan Hospital, No.
Song D, Gong WP, Xiao GL
core  

Dupilumab‐Associated Erythema Multiforme‐Like Eruption With Lichenoid Histology in a Paediatric Patient: A Case Report

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and
Paul Sun Woo Kim   +7 more
wiley   +1 more source

Novel Bispecific Engagers Targeting the CεmX Domain of mIgE‐Expressing Cells

open access: yesAllergy, EarlyView.
We developed bispecific TCE & NKCE targeting the CεmX domain of mIgE to eliminate IgE‐producing cells. Both constructs demonstrated potent, specific, dose‐dependent cytotoxicity and selective immune activation in vitro. These results highlight their promise as off‐the‐shelf, potentially curative therapeutics for IgE‐associated allergic diseases ...
Constantin Möller   +16 more
wiley   +1 more source

Dupilumab and Alopecia Areata

open access: yes
Some providers have used dupilumab off-label for the treatment of recalcitrant alopecia areata, particularly in patients with atopic dermatitis. However, many clinicians have noted mixed results, with some patients reporting improvement while other ...
Srivatsa, Anagha
core   +1 more source

Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade

open access: yesAllergy, EarlyView.
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton   +19 more
wiley   +1 more source

A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children [PDF]

open access: yes
Mingyue Wang,1– 4 Xing-Hua Gao,1– 4 Li Zhang1 1Department of Dermatology, the First Hospital of China Medical University, Shenyang, 110001, People’s Republic of China; 2NHC Key Laboratory of Immunodermatology, China Medical University, Shenyang, People’s
Wang M, Gao XH, Zhang L
core  

Dupilumab and Lichen Planus

open access: yes
The purpose of this systematic review was to assess the potential of dupilumab as a treatment for recalcitrant LP and to explore the clinical characteristics of dupilumab-induced ...
Srivatsa, Anagha
core   +1 more source

Home - About - Disclaimer - Privacy